SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is actively trending due to breaking news of a Department of Justice criminal probe into Fed Chair Jerome Powell, which the community widely perceives as unprecedented political pressure on the central bank. This development is sparking intense debate among investors about the Federal Reserve's independence and its potential impact on future monetary policy, raising concerns about market stability and the dollar's credibility.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is trending following its CES 2026 showcase, where it unveiled significant advancements in agentic voice and visual AI, including new partnerships with TomTom for multi-agent navigation and Richtech Robotics for automated food systems. The community is actively discussing these innovative applications in automotive and robotics, fueled by ongoing speculation about a potential short squeeze due to the stock's high short interest. Investors are keenly watching SOUN's position in the expanding AI market, highlighting its unique white-label solutions as a competitive advantage.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is currently trending due to heightened competitive pressures in the weight-loss market, specifically Amazon Pharmacy's offering of Novo Nordisk's oral GLP-1 at competitive prices, a product HIMS currently lacks. This news, compounded by a recent analyst downgrade, has driven significant bearish sentiment and a notable price correction. However, a segment of the community views the dip as an oversold opportunity, emphasizing HIMS' long-term strategy in personalized healthcare, proprietary compounding labs, and international expansion beyond just weight-loss treatments.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI is experiencing significant upward momentum after announcing a record total contract value exceeding $1.1 billion for 2025, fueled by data agreements with over 70 pharmaceutical and biotech companies. This major business development highlights the strength of its AI-driven precision medicine platform, sparking widespread community excitement and further institutional interest in its role in advancing drug discovery and development.

Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. The firm offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer and VeriStrat, a serum proteomic test that provides prognostic and predictive information for patients with non-small cell lung cancer. It also offers six diagnostic tests including: Nodify XL2, Nodify CDT, GeneStrat, VeriStrat, Bio-Rad SARS-CoV-2 ddPCR test and the Platelia SARS-CoV-2 test. The company was founded by David Brunel and Robert E. Cawthorn in 2005 and is headquartered in Louisville, CO.

Biodesix Inc

Biodesix (BDSX) is trending following strong preliminary financial results that anticipate beating revenue guidance and an expanded partnership with Bio-Rad Laboratories to develop high-complexity cancer diagnostic assays. This positive news, coupled with significant insider buying, has fueled a surge in interest and bullish sentiment. However, community discussions are polarized, with some celebrating growth and strategic advancements, while others remain cautious due to a recent reverse stock split and ongoing concerns about cash burn.

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions (INBS) is experiencing extreme volatility following news of a new manufacturing partnership and a $10 million private placement, sparking intense debate between its operational progress and immediate dilution concerns. Community discussion centers on the potential for a massive short squeeze, with many comparing it to previous low-float runners, while others caution about dilution from the recent offering and the stock's significant price fluctuations.

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Abivax - ADR

Abivax is trending due to intensifying speculation surrounding a potential multi-billion dollar takeover, with Eli Lilly frequently rumored as an interested suitor. The community is actively discussing the significant upside driven by its compelling Phase 3 data for its ulcerative colitis treatment, obefazimod, which positions it as a highly attractive asset in the competitive inflammatory bowel disease market. Recent reports from French officials confirming interest from multiple pharmaceutical companies are further fueling the robust buyout conversation.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is trending as news circulates about a federal investigation into the Federal Reserve Chair, which is widely seen by the community as political pressure potentially undermining the central bank's independence. This has ignited debate among investors regarding its potential market impact on tech and growth stocks, though a "buy the dip" mentality is also evident.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart is a top trending stock, driven by its strategic transfer to the Nasdaq exchange which reinforces its image as a tech-enabled e-commerce innovator. The company's recent AI partnership with Google for shopping experiences and strong performance throughout the holiday shopping period are fueling robust community discussion and multiple analyst upgrades. Investors are keenly watching its valuation as it leverages technology for continued growth in the competitive retail landscape.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is trending as investors assess the implications of a proposed cap on credit card interest rates, sparking debate about its potential impact across the fintech lending landscape. The community is actively discussing whether this could create a significant opportunity for SoFi's personal loan segment if traditional banks adjust their credit offerings, or if it poses a challenge, with many believing the cap's passage remains unlikely.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

5G Stocks To Keep An Eye On - January 8th

EchoStar, KT, and Mobix Labs are the three 5G stocks to watch today, according to MarketBeat's stock screener tool. 5G stocks are shares of companies that stand to benefit from the development...

EchoStar (NASDAQ:SATS) Reaches New 1-Year High Following Analyst Upgrade

EchoStar (NASDAQ:SATS) Reaches New 12-Month High Following Analyst Upgrade...

Boost Mobile Introduces Affordable 5G Powerhouse Duo - Samsung Galaxy A17 5G and Galaxy Tab A11+ 5G

Boost Mobile Introduces Affordable 5G Powerhouse Duo - Samsung Galaxy A17 5G and Galaxy Tab A11+ 5G Boost Mobile Introduces Affordable 5G Powerhouse Duo - Samsung Galaxy A17 5G and Galaxy Tab A11+ 5G...

Hughes Network Systems Receives Frost & Sullivan's 2025 North American Managed SD-WAN Services Customer Value Leadership Recognition for Excellence in Secure Hybrid Connectivity

Hughes Network Systems Receives Frost & Sullivan's 2025 North American Managed SD-WAN Services Customer Value Leadership Recognition for Excellence in Secure Hybrid Connectivity Hughes Network...

EchoStar (SATS) Surges 4.9%: Is This an Indication of Further Gains?

EchoStar (SATS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

5G Stocks To Research - January 6th

EchoStar, Mobix Labs, KT, Ceva, Franklin Wireless, Radcom, and Datasea are the seven 5G stocks to watch today, according to MarketBeat's stock screener tool. "5G stocks" are shares of companies...

Best 5G Stocks To Add to Your Watchlist - January 5th

EchoStar, Mobix Labs, and KT are the three 5G stocks to watch today, according to MarketBeat's stock screener tool. "5G stocks" are shares of companies that are expected to benefit from the rollout...

EchoStar Corporation Announces Additional Conversion Period for 3.875% Convertible Senior Secured Notes Due 2030

EchoStar Corporation Announces Additional Conversion Period for 3.875% Convertible Senior Secured Notes Due 2030 EchoStar Corporation Announces Additional Conversion Period for 3.875% Convertible...

EchoStar Corporation (NASDAQ:SATS) Receives Consensus Rating of "Hold" from Analysts

EchoStar Corporation (NASDAQ:SATS - Get Free Report) has received an average rating of "Hold" from the eight analysts that are covering the firm, MarketBeat.com reports. One equities research analyst...

5G Stocks To Research - January 4th

EchoStar, KT, Ceva, Mobix Labs, and Radcom are the five 5G stocks to watch today, according to MarketBeat's stock screener tool. "5G stocks" are shares of companies whose revenues and growth...

EchoStar Corp. engages in the design, development, and distribution of digital set-top boxes and products for direct-to-home satellite service providers. It operates through the following business segments: Pay-TV, Retail Wireless, and Broadband and Satellite Services. The Pay-TV segment business strategy is to be the best provider of video services in the United States by providing products with the best technology, outstanding customer service, and great value. The Retail Wireless segment offers Retail Wireless services as well as a competitive portfolio of wireless devices. The Broadband and Satellite Services segment business strategy is to maintain and improve leadership position and competitive advantage through development of technologies and services marketed to selected sectors within the consumer, enterprise and government markets globally. The company was founded by Charlie William Ergen, Candy Ergen, and James DeFranco in 1980 and is headquartered in Englewood, CO.

EchoStar Corp - Ordinary Shares - Class A

Yes — Rates Move Meaningfully Lower

Short-Term Dip, No Lasting Impact

No — Mostly Political Noise

Other – Comment Below

President Trump says he’s directing $200 billion into mortgage bond purchases to bring down rates and improve housing affordability. With questions around execution, authority, and real market impact, do you think this move will actually lower mortgage rates in 2026?

Will Trump’s Mortgage Bond Plan Actually Lower Rates in 2026?

Current Price	$120.40
Prev Close	$116.95
Open	$117.69
Dividend Yield	0.00%
50-Day Moving Average	$87.99
Beta	1.31
Avg. Volume	5.96M
PE Ratio	-2.67

52-Week High	$120.53
52-Week Low	$14.90
Market Capitalization	$34.55B
EPS (Annual)	-$0.4362
Price to Book	4.97
Revenue Per Employee	$1.16M
Enterprise Value/EBITDA	N/A

SATS
EchoStar Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SATS News

SATSEchoStar Corp